HB5327 - 104th General Assembly (2025-2026)

PRESCRIPTION LABELING
Last Action
2/10/2026 - House: Referred to Rules Committee
Statutes Amended In Order of Appearance
225 ILCS 60/33  from Ch. 111, par. 4400-33
225 ILCS 85/22  from Ch. 111, par. 4142
Synopsis As Introduced
Amends the Medical Practice Act of 1987. In provisions concerning legend drugs, provides that, at the request of a person dispensing a drug or medicine, the label affixed to a box, bottle, vessel, or package containing mifepristone, misoprostol, or any generic alternative may include the name of the dispensing health care practice instead of the name of the person dispensing the drug or medicine. Amends the Pharmacy Practice Act. In provisions concerning the label of a drug, medicine, or poison that is lawfully sold or dispensed, provides that, at a prescriber's request, the label affixed to a box, bottle, vessel, or package containing mifepristone, misoprostol, or any generic alternative may include the name of the prescribing health care practice instead of the name of the prescriber.
Actions
DateChamberAction
2/05/2026HouseFiled with the Clerk by Rep. Mary Beth Canty
2/10/2026HouseFirst Reading
2/10/2026HouseReferred to Rules Committee
2/18/2026HouseAdded Co-Sponsor Rep. Daniel Didech
2/18/2026HouseAdded Co-Sponsor Rep. Will Guzzardi